title: Novel augmentation therapy with cilostazol for the geriatric major depressive disorder patient with deep white matter hyperintensities on T2-weighted brain MRI: a case report.
authors.forename: K
authors.initials: K
authors.lastname: Takahashi
authors.forename: A
authors.initials: A
authors.lastname: Oshima
authors.forename: K
authors.initials: K
authors.lastname: Inoue
authors.forename: H
authors.initials: H
authors.lastname: Takeyoshi
authors.forename: M
authors.initials: M
authors.lastname: Fukuda
authors.forename: M
authors.initials: M
authors.lastname: Mikuni
mesh_terms: D000368:Aged; D000928:Antidepressive Agents / Q000627:therapeutic use; D001921:Brain / Q000000981:diagnostic imaging / Q000187:drug effects / Q000473:pathology*; D000077407:Cilostazol; D003865:Major Depressive Disorder / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000473:pathology*; D004357:Drug Synergism; D005260:Female; D005853:Geriatrics; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000379:methods; D009457:Neuroglia / Q000000981:diagnostic imaging / Q000187:drug effects*; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D013777:Tetrazoles / Q000627:therapeutic use*; D015899:Tomography, Emission-Computed, Single-Photon
chemical_list: D000928:Antidepressive Agents; D018696:Neuroprotective Agents; D013777:Tetrazoles; D000077407:Cilostazol